| Income Statement |
| Total Revenue | 614.00K |
|
| Revenues (USD) | 614.00K |
| Cost of Revenue | 4.00K |
| Gross Profit | 610.00K |
| Operating Expenses | 2.68M |
| Research and Development Expense | 905.00K |
| Selling, General and Administrative Expense | 1.78M |
| Operating Income | -2.07M |
| Income Tax Expense | 1000 |
| Net Income | -1.86M |
| Net Income Common Stock | -1.86M |
| Net Income Common Stock (USD) | -1.86M |
| Consolidated Income | -1.86M |
| Earnings per Basic Share | -0.11 |
| Earnings per Basic Share (USD) | -0.11 |
| Earnings per Diluted Share | -0.11 |
| Earning Before Interest & Taxes (EBIT) | -1.86M |
| Earning Before Interest & Taxes (USD) | -1.86M |
| Weighted Average Shares | 16.78M |
| Weighted Average Shares Diluted | 16.78M |
| Balance Sheet |
| Cash and Equivalents | 23.23M |
| Cash and Equivalents (USD) | 23.23M |
| Trade and Non-Trade Receivables | 531.00K |
| Current Assets | 24.43M |
| Property, Plant & Equipment Net | 481.00K |
| Total Assets | 24.91M |
| Debt Current | 246.00K |
| Total Debt | 258.00K |
| Current Liabilities | 2.05M |
| Debt Non-Current | 12.00K |
| Total Liabilities | 2.06M |
| Accumulated Retained Earnings (Deficit) | -217.45M |
| Accumulated Other Comprehensive Income | -675.00K |
| Shareholders Equity | 22.85M |
| Shareholders Equity (USD) | 22.85M |
| Assets Non-Current | 481.00K |
| Total Debt (USD) | 258.00K |
| Deferred Revenue | 103.00K |
| Liabilities Non-Current | 12.00K |
| Trade and Non-Trade Payables | 367.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 119.00K |
| Net Cash Flow from Financing | -3.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.12M |
| Capital Expenditure | -13.00K |
| Issuance (Repayment) of Debt Securities | -3.00K |
| Net Cash Flow from Investing | -13.00K |
| Net Cash Flow from Operations | -2.11M |
| Effect of Exchange Rate Changes on Cash | -3.00K |